Viking's $350M of­fer­ing; Bak­er Broth­ers leads an­oth­er PIPE

Plus, news about Ap­plied Ther­a­peu­tics, Beam Ther­a­peu­tics, Janux Ther­a­peu­tics and more:

Viking Ther­a­peu­tics sells off $350M of stock fol­low­ing pos­i­tive obe­si­ty drug da­ta: On the same day that Viking shared pos­i­tive topline da­ta for its “dou­ble G” GLP-1/GIP re­cep­tor ag­o­nist that could com­pete with Eli Lil­ly’s Zep­bound, the com­pa­ny an­nounced a pub­lic of­fer­ing, aim­ing to sell $350 mil­lion of its shares. Viking said it would use the mon­ey to de­vel­op its obe­si­ty drug as well as oth­ers in its pipeline. — Kather­ine Lewin

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.